{
  "age": 15,
  "gender": {
    "category": "Female",
    "intersex_condition": null
  },
  "weight": {
    "weight_kg": 63,
    "height_cm": 172,
    "bmi_category": "Healthy"
  },
  "ethnicity": "East Asian",
  "disease": {
    "name": "Acute myeloid leukaemia of childhood",
    "diagnosed_years_ago": 6,
    "prognosis": "Terminal"
  },
  "comorbidities": [
    {
      "name": "Chronic Graft vs Host Disease",
      "diagnosed_years_ago": 1,
      "prognosis": "Worsening"
    }
  ],
  "treatments": [
    {
      "treatment_name": "Cytarabine",
      "dosage_mg_per_day": 115,
      "percent_week_administered": 100,
      "indication": "Primary"
    },
    {
      "treatment_name": "Daunorubicin",
      "dosage_mg_per_day": 14,
      "percent_week_administered": 43,
      "indication": "Primary"
    },
    {
      "treatment_name": "Mycophenolate mofetil",
      "dosage_mg_per_day": 15,
      "percent_week_administered": 200,
      "indication": "Comorbidity"
    },
    {
      "treatment_name": "Prednisone",
      "dosage_mg_per_day": 63,
      "percent_week_administered": 100,
      "indication": "Comorbidity"
    }
  ],
  "genetic_variants": [
    {
      "variant_name": "TP53 R175H",
      "associated_risks": ["Poor prognosis in AML"]
    }
  ]
}




